Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05150652
Title Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Emily Marcinkowski
Indications

breast cancer

Therapies

Exemestane

Tamoxifen

Letrozole

Anastrozole

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.